West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics
West Pharmaceutical Services, Inc. (WST)
Today's Latest Price: $266.38 USD
Updated Aug 10 7:00pm
Add WST to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
WST Stock Summary
- WST has a higher market value than 90.65% of US stocks; more precisely, its current market capitalization is $20,199,119,655.
- WST's went public 32.61 years ago, making it older than 89.34% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for WST is currently 48.13, higher than 92.4% of US stocks with positive operating cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to West Pharmaceutical Services Inc are SLP, AMRN, CARG, ALGN, and INSP.
- Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.
WST Stock Price Chart Technical Analysis Charts
WST Price/Volume Stats
| Current price | $266.38 | 52-week high | $279.54 |
| Prev. close | $273.55 | 52-week low | $124.53 |
| Day low | $265.64 | Volume | 617,851 |
| Day high | $273.41 | Avg. volume | 660,112 |
| 50-day MA | $235.13 | Dividend yield | 0.23% |
| 200-day MA | $179.65 | Market Cap | 19.67B |
West Pharmaceutical Services, Inc. (WST) Company Bio
West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.
WST Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $266.38 | $90.91 | -67% |
We started the process of determining a valid price forecast for West Pharmaceutical Services Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that West Pharmaceutical Services Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of West Pharmaceutical Services Inc, consider:
- The company's debt burden, as measured by earnings divided by interest payments, is 42.96; that's higher than 90.53% of US stocks in the Healthcare sector that have positive free cash flow.
- The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than just 7.53% of the free cash flow producing stocks we're observing.
- WST's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 51.57% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -67% |
| 1% | -67% |
| 2% | -67% |
| 3% | -66% |
| 4% | -66% |
| 5% | -66% |
Want more companies with a valuation profile/forecast similar to that of West Pharmaceutical Services Inc? See MTD, OFIX, ABT, SRDX, and BAX.
Loading social stream, please wait...